Int J Reprod Biomed. 2020 Sep 20;18(9):747-754. doi: 10.18502/ijrm.v13i9.7669. eCollection 2020 Sep.
Role of the 820 A/G variant in the .
International journal of reproductive biomedicine
Farzaneh Ardeshir, Leila Keshavarz, Fatemeh Asadian, Gohar Omidmokhtarkhanloo, Majid Yavarian
Affiliations
Affiliations
- Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran.
- Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
- Persian Bayan Gene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Siraz, Iran.
- Shiraz Nephron-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
PMID: 33062920
PMCID: PMC7521167 DOI: 10.18502/ijrm.v13i9.7669
Abstract
BACKGROUND: Insulin-like growth factor-2 (
OBJECTIVE: This cross-sectional study aimed to investigate the role of 820A/G variant of the
MATERIALS AND METHODS: In this study, 50 aborted fetuses tissue for the study group and blood samples umbilical-cord from newborns as control group (n = 50) were collected from Shiraz-Iran (2017). The genotyping of the target point in the
RESULTS: Based on the collected data (AA genotype = reference), allele "A" frequency in aborted fetus was 51% and control 68% as well as allele G 49% and 32%, respectively. Moreover, 27 aborted embryos (54%) were heterozygous (A/G) (OR = 3.274, 95% CI = 1.015-10.561, p = 0.04), while 18 cases (36%) in control sample showed heterozygosity. Considering the phenotypic status, the G allele had a dominant effect on the incidence of RSA (p = 0.008, OR = 3.167).
CONCLUSION: Based on the present study, the risk of abortion due to loss of heterozygosity or quantitative decline of the
Copyright © 2020 Ardeshir et al.
Keywords: Gene expression; Genomic imprinting; IGF-2; Spontaneous abortion; Variant
Conflict of interest statement
There is no conflict of interest in this study.
References
- J Endocrinol. 2004 Dec;183(3):487-96 - PubMed
- Int J Mol Med. 2011 Oct;28(4):481-7 - PubMed
- Obstet Gynecol Int. 2010;2010:965905 - PubMed
- J Clin Endocrinol Metab. 2003 Oct;88(10):4811-7 - PubMed
- Endocr Dev. 2009;14:20-8 - PubMed
- Genome Biol. 2011 Mar 21;12(3):106 - PubMed
- Hum Mol Genet. 2004 Apr 1;13(7):715-25 - PubMed
- Genet Epigenet. 2013 Mar 10;5:17-22 - PubMed
- Curr Opin Obstet Gynecol. 2012 Aug;24(4):229-34 - PubMed
- Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8309-14 - PubMed
- Lab Invest. 1998 May;78(5):641-2 - PubMed
- Am J Med Genet A. 2009 Nov;149A(11):2415-23 - PubMed
- Cancer Res. 2002 Nov 15;62(22):6442-6 - PubMed
- Cold Spring Harb Symp Quant Biol. 1985;50:45-50 - PubMed
- Mol Reprod Dev. 1997 Jun;47(2):134-9 - PubMed
- J Clin Endocrinol Metab. 2001 Aug;86(8):3665-74 - PubMed
- Am J Reprod Immunol. 2008 Aug;60(2):111-7 - PubMed
- Mol Cell Biol. 1996 Jun;16(6):2802-13 - PubMed
- Hum Mol Genet. 2003 Mar 1;12(5):535-49 - PubMed
- J Cell Physiol. 2002 Sep;192(3):245-58 - PubMed
- J Physiol. 2003 Feb 15;547(Pt 1):35-44 - PubMed
- Am J Obstet Gynecol. 1984 Jan 15;148(2):140-6 - PubMed
- Chang Gung Med J. 2006 Jan-Feb;29(1):25-36 - PubMed
- J Clin Endocrinol Metab. 2007 Aug;92(8):3148-54 - PubMed
- Br J Cancer. 2000 Jan;82(2):385-91 - PubMed
- Diabetes. 2003 Jun;52(6):1403-8 - PubMed
- Acta Obstet Gynecol Scand. 2010 Mar;89(3):360-6 - PubMed
- Nat Genet. 1997 Feb;15(2):122-3 - PubMed
- J Biol Chem. 1996 May 10;271(19):11330-8 - PubMed
- Am J Reprod Immunol. 2012 Apr;67(4):334-40 - PubMed
Publication Types